BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

266 related articles for article (PubMed ID: 10623016)

  • 1. Public sector HMO members report more hospital days in Medicaid, Medicare study.
    Health Care Cost Reengineering Rep; 1999 Sep; 4(9):142-4. PubMed ID: 10623016
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Administrative benchmarks for Medicare, Medicaid HMOs.
    Public Sect Contract Rep; 1998 Nov; 4(11):171-2. PubMed ID: 10187427
    [TBL] [Abstract][Full Text] [Related]  

  • 3. New M&R benchmarks reveal HMO industry trends.
    Capitation Rates Data; 2001 Jan; 6(1):1-4. PubMed ID: 11209210
    [No Abstract]   [Full Text] [Related]  

  • 4. HMO study identifies leading cancers among seniors, offers cost and utilization benchmarks.
    Public Sect Contract Rep; 1998 Feb; 4(2):30-1. PubMed ID: 10177571
    [TBL] [Abstract][Full Text] [Related]  

  • 5. At a glance. Medicare HMO penetration for selected states.
    Healthc Financ Manage; 1998 Oct; 52(10):20. PubMed ID: 10187610
    [No Abstract]   [Full Text] [Related]  

  • 6. Differences in U.S. hospital service utilization between traditional Medicare and Medicare HMO patients.
    Revere L; Sear A
    J Health Hum Serv Adm; 2004; 27(3):347-74. PubMed ID: 16318038
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Medicare members like plans, providers, but could be happier.
    Public Sect Contract Rep; 1999 Mar; 5(3):43-5. PubMed ID: 10351424
    [No Abstract]   [Full Text] [Related]  

  • 8. Use these benchmarks to assess the strength of your Medicare HMO.
    Public Sect Contract Rep; 1999 Jul; 5(7):108-9. PubMed ID: 10539511
    [TBL] [Abstract][Full Text] [Related]  

  • 9. By the numbers. Medicare/Medicaid.
    Mod Healthc; 2002 Dec; Suppl():16. PubMed ID: 12528224
    [No Abstract]   [Full Text] [Related]  

  • 10. HMOs rule in Boston market. But costs, utilization are high.
    Morrissey J
    Mod Healthc; 1998 Sep; 28(37):56-8, 60-2, 64-5. PubMed ID: 10183094
    [No Abstract]   [Full Text] [Related]  

  • 11. Stats & facts. Disenrollment rates: issues and concerns.
    Manag Care Interface; 1999 Jun; 12(6):44-5. PubMed ID: 10538459
    [No Abstract]   [Full Text] [Related]  

  • 12. Impact of managed care varies by payer and region.
    Data Strateg Benchmarks; 1997 Oct; 1(4):62-3. PubMed ID: 10345337
    [TBL] [Abstract][Full Text] [Related]  

  • 13. By the Numbers. Medicare and Medicaid.
    Mod Healthc; 2001 Dec; 31(52 Suppl):10-1. PubMed ID: 11808389
    [No Abstract]   [Full Text] [Related]  

  • 14. Utilization rates vary based on HMO ownership, finds study of comparative hospital data.
    Data Strateg Benchmarks; 1997 Aug; 1(2):29-30, 17. PubMed ID: 10345332
    [TBL] [Abstract][Full Text] [Related]  

  • 15. AMGA utilization data help providers anticipate senior market.
    Capitation Rates Data; 1997; 2():73-5. PubMed ID: 11066343
    [No Abstract]   [Full Text] [Related]  

  • 16. Managed care outlook. Variance in Medicare pharmacy benefits is wide.
    Manag Care; 1999 Oct; 8(10):66. PubMed ID: 10661956
    [No Abstract]   [Full Text] [Related]  

  • 17. Hospitals, managed care, and the charity caseload in California.
    Currie J; Fahr J
    J Health Econ; 2004 May; 23(3):421-42. PubMed ID: 15120464
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparing mortality and time until death for medicare HMO and FFS beneficiaries.
    Maciejewski ML; Dowd B; Call KT; Feldman R
    Health Serv Res; 2001 Feb; 35(6):1245-65. PubMed ID: 11221818
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Executive overview of Michigan HMO trends. Michigan Health & Hospital Association.
    Mich Health Hosp; 1996; 32(3):suppl 1-21. PubMed ID: 10157724
    [No Abstract]   [Full Text] [Related]  

  • 20. Study finds managed Medicaid market starting to fizzle.
    Public Sect Contract Rep; 1998 Jul; 4(7):110-1. PubMed ID: 10181417
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 14.